Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition capable of reducing uric acid and resisting gout, and preparation method and application of composition

An anti-gout and uric acid-lowering technology, applied to a composition with anti-gout function and preparation thereof, has the field of uric acid lowering, and can solve the problems of inability to enhance the inhibition of uric acid generation, limited inhibition of uric acid generation, and lowering of blood uric acid levels, and the like. The effect of inhibiting uric acid production, increasing uric acid excretion, and reducing blood uric acid levels

Active Publication Date: 2020-09-04
BEIJING TONGRENTANG HEALTH PHARMA
View PDF14 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among the above patents, patents CN1572318A and CN106317178A mainly use oligopeptides such as dipeptides and tripeptides to inhibit the production of uric acid, thereby reducing blood uric acid levels, but there are no traditional Chinese medicine ingredients that can promote the excretion of uric acid, which cannot better promote the excretion of uric acid; patent CN106805234A Although it has diuretic effect by adding bamboo leaves and Poria cocos medicinal and edible raw materials, it can not enhance the effect of inhibiting uric acid production; and patent CN107495340A only uses medicinal and edible homologous raw materials to inhibit uric acid production and promote uric acid excretion, and it inhibits uric acid production limited role
So far, no combination of marine fish oligopeptides, medicinal and edible Chinese herbal medicines and fruit raw materials has been found that can not only inhibit uric acid production, but also promote uric acid excretion and reduce hyperuricemia-related complications

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition capable of reducing uric acid and resisting gout, and preparation method and application of composition
  • Composition capable of reducing uric acid and resisting gout, and preparation method and application of composition
  • Composition capable of reducing uric acid and resisting gout, and preparation method and application of composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] 100 parts of the uric acid-lowering and anti-gout composition described in this example are made of the following raw materials in parts by weight: 6 parts of marine fish oligopeptides, 24 parts of Hovenia dulcis, 10 parts of chicory, 30 parts of dandelion, and 5 parts of mango powder , 10 parts of acerola cherry powder, 2 parts of monk fruit, 0.2 part of steviol glycoside, and the rest is maltodextrin. [Here, the maltodextrin is represented by the remaining amount of parts. In the middle of the claim, it is 5%-10% maltodextrin in the concentrated solution, so it is easy to cause doubts: 5%-10% maltodextrin in the concentrated solution Is it necessarily corresponding to the remaining amount? It is suggested that the two should be unified. For example, in claim 1, the number of parts of maltodextrin is limited, and it will not be expressed according to the volume ratio in the subsequent concentrated solution]

[0041] The preparation method of this embodiment is as follo...

Embodiment 2

[0048] Embodiment 2: 100 parts of the uric acid-lowering and anti-gout composition described in this embodiment are made of the following raw materials in parts by weight: 8 parts of marine fish oligopeptides, 20 parts of Hovenia dulcis, 12 parts of chicory, 25 parts of dandelion, 7 parts of mango powder, 8 parts of acerola powder, 5 parts of monk fruit, 0.2 part of sucralose, and the rest is maltodextrin.

[0049] The preparation method of this embodiment is as follows:

[0050] Step (1), the raw material acceptance of the composition of the present invention, the marine fish oligopeptide used is checked and accepted according to the national standard GBT22729-2008; the content of mangiferin in mango powder ≥ 100mg / 100g, and the content of VC in acerola cherry ≥ 60%; according to "China The Monk Fruit standard in Pharmacopoeia is accepted; steviol glycoside is accepted according to GB 8270 national food safety standard; sucralose is accepted according to GB 25531 national foo...

Embodiment 3

[0056] Embodiment 3: 100 parts of the uric acid-lowering and anti-gout composition described in this embodiment are made of the following raw materials in parts by weight: 10 parts of marine fish oligopeptides, 18 parts of Hovenia dulcis, 15 parts of chicory, 20 parts of dandelion, 10 parts of mango powder, 6 parts of acerola cherry powder, 8 parts of Luo Han Guo, 1 part of steviol glycoside, and the rest is maltodextrin.

[0057] The preparation method of this embodiment is as follows:

[0058] Step (1), the raw material acceptance of the composition of the present invention, the marine fish oligopeptide used is checked and accepted according to the national standard GBT22729-2008; the content of mangiferin in mango powder ≥ 100mg / 100g, and the content of VC in acerola cherry ≥ 60%; according to "China The Monk Fruit standard in Pharmacopoeia is accepted; steviol glycoside is accepted according to GB 8270 national food safety standard; sucralose is accepted according to GB 25...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a composition capable of reducing uric acid and resisting gout, and a preparation method and application of the composition. The composition comprises the following raw materials in parts by weight: 6-20 parts of ocean fish oligopeptide, 12-24 parts of semen hoveniae, 10-20 parts of chicory, 15-30 parts of dandelions, 5-15 parts of mango powder, 2-10 parts of needle-leaf cherry powder, 2-10 parts of fructus momordicae and 0.2-2 parts of sweetener. The composition has the beneficial effects that the ocean fish oligopeptide is compounded with medicine-food homologous rawmaterials, i.e., the semen hoveniae, the chicory and the dandelions and fruit raw materials, i.e., the mango powder and the needle-leaf cherry powder, so that the composition can be used for inhibiting production of the uric acid, promoting excretion of the uric acid and alleviating complications such as hyperuricemia; and the composition has a synergistic action and can better lower a blood uricacid level and achieve the action of resisting the gout. The composition is safe in long-term taking and free of side effects.

Description

technical field [0001] The invention relates to the field of health food, in particular to a composition with functions of lowering uric acid and anti-gout, a preparation method and application thereof. Background technique [0002] Gout is a group of diseases that cause tissue damage due to the increase of blood uric acid due to the disorder of purine metabolism. It is the second largest metabolic disease after diabetes. In ancient times, it often occurred in emperors and generals, and it was also called "disease of wealth". Its clinical symptoms are: hyperuricimia; recurrent acute and chronic arthritis and soft tissue damage caused by urate deposition; gouty nephropathy caused by uric acid kidney stones, often accompanied by obesity, Hyperlipidemia, diabetes, hypertension, and cardiovascular and cerebrovascular diseases. According to statistics: 90% of gout patients will cause complications such as yang deficiency, nephritis, stones and other chronic kidney diseases and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/02A61P19/06A61K36/72
CPCA61K38/02A61K36/72A61K36/28A61K36/288A61K36/22A61K36/185A61K36/42A61P19/06A61K2236/331A61K2236/39A61K2236/51A61K2300/00
Inventor 张宏查圣华王俊亮
Owner BEIJING TONGRENTANG HEALTH PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products